treatment: AATD

Alpha-1 Antitrypsin Deficiency (AATD) – 11 Months

We require patients with Alpha-1 Antitrypsin Deficiency (AATD) and Emphysema for a new study.

This study will be approximately 37 visits to the unit and will spread over approximately 11-12 months.

A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.